✦ LIBER ✦

348 Concurrent full-dose cisplatin and etoposide chemotherapy with radical thoracic irradiation for unresectable non-small cell lung cancer (NSCLC)

✍ Scribed by Millward, M.J.; Tebbutt, N.; Wirth, A.; Ryan, G.; Ball, D.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Unresectable non-small cell lung cancer

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Irinotecan plus cisplatin chemotherapy f

✍ Hanan A. Wahba; Amal A. Halim; Hend A. El-Hadaad 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 211 KB

Dose-Escalated Hypofractionated Intensit

✍ Kim, J.; Ghosh, S.; Roa, W.H. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

252 Combination chemotherapy followed by

✍ Ardizzoni, A.; Grossi, F.; Scolaro, D.; Giudici, S.; Pennucci, C.; Cafferata, M. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Phase I study of pemetrexed and cisplati

✍ Mornex, Françoise; Peignaux, Karine; Germain, Thierry; Wautot, Virginie; Chouaki 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 260 KB

Pilot study of etoposide and split-dose

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 140 KB